In the past nothing has come of similar attempts to find a treatment.
The drug with the name CPHPC is thought to reduce the volume of a protein that causes the disease. Research shows that the protein had vanished from the brains of five patients with dementia after they had been using the drug for three months.
There have not yet been sufficient tests to predict the long term effect of the drug and to show clinical improvements. However, it can be said that the results from the study are very promising.
So far, no side-effects of the drug have emerged. The body does not break it down and the drug works locally without influencing other cells.
The British scientists will further develop the drug to prove its safety and action. The results of the research carried out by University College London have been published in the journal Proceedings of the National Academy of Sciences.